Edition:
United Kingdom

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

2.77USD
18 May 2018
Change (% chg)

$0.04 (+1.47%)
Prev Close
$2.73
Open
$2.72
Day's High
$2.79
Day's Low
$2.70
Volume
6,143
Avg. Vol
50,944
52-wk High
$7.68
52-wk Low
$1.84

Select another date:

Tue, May 8 2018

BRIEF-Sunesis Pharmaceuticals Qtrly Loss Per Share $0.21

* SUNESIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

BRIEF-Sunesis Pharmaceuticals Announces Cancellation Of Presentation And Webcast At Cowen & Company 38Th Annual Health Care Conference

* SUNESIS PHARMACEUTICALS ANNOUNCES CANCELLATION OF PRESENTATION AND WEBCAST AT COWEN & COMPANY 38TH ANNUAL HEALTH CARE CONFERENCE

BRIEF-Sunesis Pharma Qtrly Loss Per Share $0.21

* SUNESIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

BRIEF-Boxer Capital Llc Reports 6.2 Percent Passive Stake In Sunesis Pharmaceuticals Inc

* BOXER CAPITAL, LLC REPORTS 6.2 PERCENT PASSIVE STAKE IN SUNESIS PHARMACEUTICALS INC AS OF FEBRUARY 21, 2018 Source text: (http://bit.ly/2H6YWUT) Further company coverage:

BRIEF-Sunesis Pharmaceuticals Inc - Daniel Swisher Resigns As CEO Effective End Of 2017

* SUNESIS PHARMACEUTICALS INC - DANIEL SWISHER RESIGNS AS CEO EFFECTIVE END OF 2017

BRIEF-Sunesis Pharmaceuticals Appoints William Quinn As CFO

* SUNESIS PHARMACEUTICALS APPOINTS WILLIAM QUINN AS CHIEF FINANCIAL OFFICER AND SENIOR VICE PRESIDENT, FINANCE AND CORPORATE DEVELOPMENT

Select another date: